Key facts
- Noctrix Health’s last known valuation is $140.0M (Jan 2024).
- It has raised $93.9M across 1 recorded rounds; the latest was Early Stage VC ($16.9M) in Jan 2021.
- Notable investors include Joyance Partners, OrbiMed, Seraph Group, Angelini Ventures, Andrew Nealon — 20 tracked in total.
- Noctrix Health has filed 1 Form D with the SEC, most recently Jan 2021 ($16.9M sold to 11 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 20 names
- ·Watchlist + deal alerts for Noctrix Health
Funding rounds
1 roundsAbout Noctrix Health
Developer of wearable therapeutic devices designed to treat the symptoms of restless leg syndrome. The company's device harnesses the power of neural circuitry to relieve symptoms, and facilitates undisturbed sleep, enabling patients to empower and take control of their chronic medical conditions.
- Sector
- Healthcare
- HQ
- Pleasanton, CA, United States
- Founded
- 2016
- Employees
- 35
- Website
- noctrixhealth.com/
- Ownership
- Privately Held (backing)
Noctrix Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Noctrix Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Noctrix Health in its N-PORT filings yet. We sweep new filings monthly.